We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Dell
DELL
$248B
| $358K | 0.18% |
+2,846
| New | +$401K |
|
|
AUGO
177
Aura Minerals Inc
AUGO
$4.58B
| $358K | 0.18% |
7,106
+1,065
| +18% | +$41.8K |
|
178
Alignment Healthcare
ALHC
$3.85B
| $358K | 0.18% |
+18,122
| New | +$326K |
|
179
EVgo
EVGO
$223M
| $357K | 0.18% |
122,843
+102,754
| +511% | +$373K |
|
180
Gentex
GNTX
$5.07B
| $357K | 0.18% |
+15,353
| New | +$370K |
|
|
EFOR
181
Everforth Inc
EFOR
$952M
| $357K | 0.18% |
+7,411
| New | +$342K |
|
182
Porch Group
PRCH
$1.35B
| $357K | 0.18% |
+39,081
| New | +$471K |
|
|
ORC
183
Orchid Island Capital
ORC
$1.3B
| $357K | 0.18% |
49,537
+15,812
| +47% | +$115K |
|
184
Xylem
XYL
$29.6B
| $356K | 0.18% |
+2,614
| New | +$376K |
|
185
Masco
MAS
$16.5B
| $353K | 0.18% |
5,566
-941
| -14% | -$61.1K |
|
186
MediWound
MDWD
$191M
| $352K | 0.18% |
+19,064
| New | +$348K |
|
|
NUTX
187
Nutex Health
NUTX
$1.01B
| $351K | 0.18% |
2,133
-1,929
| -47% | -$256K |
|
188
Vitamin Cottage Natural Grocers
NGVC
$755M
| $351K | 0.18% |
+14,013
| New | +$449K |
|
189
Performance Food Group
PFGC
$18B
| $351K | 0.18% |
+3,900
| New | +$377K |
|
190
Avista
AVA
$3.48B
| $351K | 0.18% |
9,095
+1,755
| +24% | +$68.5K |
|
191
SiteOne Landscape Supply
SITE
$4.57B
| $350K | 0.18% |
+2,811
| New | +$356K |
|
192
Allot
ALLT
$377M
| $350K | 0.18% |
35,604
+15,417
| +76% | +$148K |
|
193
nLIGHT
LASR
$3.59B
| $350K | 0.18% |
9,327
-6,781
| -42% | -$226K |
|
|
TTAN
194
ServiceTitan Inc
TTAN
$7.65B
| $350K | 0.18% |
+3,283
| New | +$321K |
|
195
Intercorp Financial Services
IFS
$6.48B
| $349K | 0.18% |
+8,245
| New | +$339K |
|
196
Blue Bird Corp
BLBD
$2.32B
| $348K | 0.18% |
+7,411
| New | +$387K |
|
|
SFIX
197
Stitch Fix
SFIX
$562M
| $348K | 0.18% |
+66,326
| New | +$303K |
|
198
CareDx
CDNA
$1.85B
| $348K | 0.18% |
+18,453
| New | +$309K |
|
199
FIGS
FIGS
$1.71B
| $347K | 0.18% |
30,568
-18,445
| -38% | -$173K |
|
200
Genuine Parts
GPC
$17.8B
| $347K | 0.18% |
+2,822
| New | +$365K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.